Using a fingerstick test for haematological monitoring in patients treated with clozapine
Background Treatment with clozapine requires regular blood monitoring in order to minimise the risk of agranulocytosis. The demands on patients and clinicians associated with monitoring may be reduced by using point-of-care, as opposed to lab-based assessments. We assessed the utility of a device th...
Saved in:
Main Authors: | Matthew Atkins (Author), Philip McGuire (Author), Bhirundra Balgobin (Author), Pravinkumar Patel (Author), David Taylor (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Feasibility of Portable Fingerstick Cholinesterase Testing in Adolescents in South Texas
by: Amber B. Trueblood, et al.
Published: (2019) -
Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies.
by: Joseph Lykins, et al.
Published: (2018) -
Clozapine clinical toolkit optimizes inpatient clozapine monitoring
by: Brooke Gessner, PharmD, ACPR, et al.
Published: (2024) -
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidence
by: Ebenezer Oloyede, et al.
Published: (2022) -
Pharmacists in clozapine clinics improving physical health monitoring
by: Greg Spann, BPharm, GCert Psychiatric Therapeutics, et al.
Published: (2022)